SOURCE-LINKED INTELLIGENCE
THE BLUE BOX: A NEW AGE FOR BREAST CANCER DIAGNOSTICS
THE BLUE BOX: A NEW AGE FOR BREAST CANCER DIAGNOSTICS THE BLUE BOX BIOMEDICAL SOLUTIONS S.L. is a deep tech European start-up developing a medical device based on Artificial Intelligence, capable of detecting breast cancer using urine samples, with 95% accuracy. The Blue Box presents higher performance and safety features as compared to competing technologies (mammography, MRI and gene testing): It is NON-INVASIVE unlike mammography, as it uses urine samples, NON-IRRADIATING unlike mammography that makes use of radioactive materials, USER FRIENDLY as anyone can perform the test, LOW COST (<150 €) and it can be used by several family members. The Blue Box business plan includes two business models: one oriented to final consumers (B2C), mostly women within the US market, and the other one oriented to hospitals and health centres (B2B), oriented to the EU market. The objective of this Women TechEU project is to assist in the scaling up of the company on the Key Partners Box of the business plan, providing support to the OUTSOURCING of 3D printing a
Read original source ↗ Open in workspace
- recordType
- award
- status
- CLOSED
- region
- EU
- value
- 75000
- unit
- EUR
Evidence & attribution
European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.
License: CORDIS reuse policy
First collected: 2026-09-20T00:21:03.701Z. This is not the publication date.